The test of your character is what it takes to stop you!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good 2 c u too! People are always searching for an OTC that can uplist to NASDAQ. Well, here it is $GTBP. I'm currently waiting on NASDAQ approval and then guess what happens...
OXS-3550 TRiKe looks even more promising than OXS-1550
http://bispecific.com/wp-content/uploads/sites/90/2016/10/Vallera-TRiKEs.pdf
https://ash.confex.com/ash/2016/webprogram/Paper93724.html
http://stm.sciencemag.org/content/8/328/328ec35
That's what I'm waiting for as well. That news update can be a good momentum driver for GTBP
>>>>The economic impact of cancer is significant and is increasing. The total annual economic cost of cancer in 2015 was estimated at approximately US$ 2.5 trillion <<<<<
This is shockingly true! Although the economic burden of each cancer case in the United States, the United Kingdom, and Japan ranges between $183-$460 per patient every year, in South America, India, and China it ranges a paltry $0.54-$7.92 per patient. Overall, high-income regions spend 5-10 times more on cancer control on a per capita basis than low- and middle-income countries.
Spot on Blockchain! The OXS-C3550 TriKE was developed following continued research with the TriKE platform at the University of Minnesota Masonic Cancer Center. As demonstrated in non-clinical models, this targeted immunotherapy directs immune cells to kill cancer cells while diminishing drug-related toxicity.
The TriKE platform technology can be viewed as a protein version of CAR-T. However, unlike traditional CAR-T platforms, it is anticipated that TriKEs could service a much larger part of the cancer population at a fraction of the cost. TriKEs are an antibody platform that could be tailored to treat any form of cancer, liquid or solid tumors.
Unlike traditional CAR-T platforms, TriKEs are potentially a cost effective cell therapy and not relegated to treating liquid tumors only.
IMO $GTBP have shown consistency this whole week as well as today even though the market is a bit slow... lets see what happens going next week.
$PAOG clinic in Sandusky Register http://www.sanduskyregister.com/story/201708150032 … #MMJ #opioidcrisis
I've been watching GTBP for a while now, I like how they're starting to diversify their treatments and attacking different niches. Over the last year, the company has done a great job improving their management team with experienced industry veterans who have big pharma experience and have taken drugs from trials to market. Something very uncommon in a lot of other OTC biotechs from my experience.
OXS-3550 TriKE has been proven to superior to OXS-1550 in in vivo studies, so I don't expect OXS-1550 to pass Phase II trials, however OXS-3550 TriKE most likely will. As it has been proven to be more effective than Rituxan in killing cancer cells.
PainBrake will use a patented technology - and unique shape - that allows tablets to be easily broken into smaller, precise doses, for maximum dose flexibility and accuracy.
Nice article, I think there's a good shot for long term potential here. Consider What GT Biopharma Could Be In The Future
http://en.hnosc.com/?gclid=EAIaIQobChMIpofokszs2gIVRhJoCh39sggFEAEYASAAEgJMr_D_BwE
Hoping for a pop..the potential is there.
I feel it's a matter of breaking through the 1.60 level WITH VOLUME and even though volume's been strong, I think another above average day to the upside will be a nice catalyst for another move.
I guess we'll see what happens..
Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of Directors
https://ir.gtbiopharma.com/press-releases/detail/142/seasoned-financial-executive-federica-obrien-joins-gt
Hello Antminer!!!
$GTBP green open friday for biotech stocks..
Thanks for the link, Blockchain.
What exactly is the potential in the pipeline?
TRUE! I'm hoping we can get an update soon for GTBP. In my opinion, this company has a lot of long-term potentials the thing with biotechs is everything is such a grind and a process.
Well when all the clinics open up, and next years revenues start rolling in, it will be another story. This is going to be one heck of a ride!! Financial freedom!!
Taxi- I think volume is the key here-
if we can get 5 mil. volume, we're gonna break Pennyland if not tomorrow - definitely next week. Things are about to go absolutely nuts in the MJ sector.
2018 will be an AWESOME YEAR for entire MJ stock sector. GO PAOG $$$$$$$$
BUCKLE UP! ITS GTBP POWER HOUR!!!!!!
It will be a while but I think after they file it this stock will see an upward motion.
OXS-3550 for liquid tumors. The TRiKE platform has shown promising in vivo data compared to
BiKEs . (The addition of Il-15 created NK cell proliferation resulting in 60-70% remission vs 30-
50% for BiKE)
OXS-4550 Again using the TRiKE platform In Vivo data isn't yet, however Dr. Miller assured me in
the email that they've made significant progress with it.
OXS-4235 There's a chance (albeit slim) that this Multiple Myeloma drugs enters the clinic this
year
LOL! Cant wait for this to get onto Nasdaq to get some eyes on the stock.
Sishing all the best smile if FDA or NASDAQ news was confirmed, i will be ecstatic
Great article for today so far. A good revised team and some positive plans will make this stock climb again for those that are patient.
8 Clinics I can only dream what the revs are going to look like in the future!
$PAOG - is my future - that is for sure!
Thanks Blockchain!!
Nice breakdown man! $PAOG going to be the stock of 2018 and well on it's way. Slow and steady...
looking good! Ride a Bull, Slap a Bear!!
Good question... I feel that with that nasdaq bump it will start its upward movement.
GT Biopharma’s pipeline of therapies have attracted several industry heavyweights that hail from companies like Pfizer (PFE), Chase Pharmaceuticals, Sanofi (SNY), and Deutsche Bank (DB). GT Biopharma’s pipeline includes numerous treatments in or about to be in Phase II trials as well as other treatments in preclinical trials.
This is awesome!!! Go $GTBP
Have you seen what this stock has done the last 6 months? This is a swing / long term trade based on fundamentals. A low float + innovative bio tech = Profits
That's what I'm waiting for as well. That news update can be a good momentum driver for GTBP.
Good morning Blockchain!! Good to see you!!!
People are always searching for an OTC that can uplist to NASDAQ. Well, here it is $GTBP. Waiting currently on NASDAQ approval and then see what happens.
This is one of very few stocks I have ever seen that can make a move from the OTC to the Nasdaq. GTBP is on track to do it, Keep a close eye on these trials and volume. I have a feeling its coming sooner then later. The up list.
So far GTBP has had pretty consistent volume over the past 2 weeks I think when the next PR is released it will give the juice they need to potentially run past 1.60. Imo I do believe that move will happen just a matter of time
IMO $GTBP have shown consistent momo this whole week as well as today even though the market is a bit slow... lets see what happens going into power hour
I think with a little boost in volume we may be in the 1.60's